secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001193125-23-277147
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Korro Bio enters new employment agreements with CEO and CFO with enhanced change-in-control severance
--------------------------------------------------------------------------------

- CEO Ram Aiyar: base $498,487, target bonus 45% of base; CFO Vineet Agarwal: base $426,483, target bonus 35%.
- Outside CIC severance: CEO 12 months base + pro rata bonus + 12 months COBRA; CFO 9 months base + pro rata bonus + 9 months COBRA.
- Within CIC severance: CEO 18 months base + 1.5x bonus + accelerated vesting; CFO 12 months base + 1.0x bonus + accelerated vesting.
- Agreements supersede prior offer letters, formalizing compensation previously disclosed; effective November 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523277147/0001193125-23-277147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523277147/d416540d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-277147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer